These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7863786)

  • 1. Preparation and activity of derivatives of 1,2,3,4-tetrahydroisoquinoline- 4,6,8-triol, as potential beta-adrenergic blockers.
    Brzezińska E
    Acta Pol Pharm; 1994; 51(2):137-41. PubMed ID: 7863786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological investigations of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Brzezinska E; Venter D; Glinka R
    Pharmazie; 1996 Jun; 51(6):397-9. PubMed ID: 8767849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological properties of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Brzezińska E
    Acta Pol Pharm; 1996; 53(1):25-9. PubMed ID: 8960281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 1-substituted analogues of trimetoquinol possessing differential and selective beta-adrenergic properties.
    Miller DD; Osei-Gyimah P; Raman RV; Feller DR
    J Med Chem; 1977 Nov; 20(11):1502-4. PubMed ID: 21293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents.
    Kakefuda A; Watanabe T; Taguchi Y; Masuda N; Tanaka A; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):390-8. PubMed ID: 12672990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6,7-Dichloro-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline . A structurally novel beta-adrenergic receptor blocking agent.
    Kaiser C; Oh HJ; Garcia-Slanga BJ; Sulpizio AC; Hieble JP; Wawro JE; Kruse LI
    J Med Chem; 1986 Nov; 29(11):2381-4. PubMed ID: 2878080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol].
    Gries J; Unger L; Einig H; Friedrich L; Hofmann HP; Kreiskott H; Lehmann HD; von Philipsborn G; Wuppermann D; Zimmermann F
    Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological properties of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives.
    Brzezińska E
    Acta Pol Pharm; 1996; 53(5):365-71. PubMed ID: 9415212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of new 6,7-dichloro-3,4-dihydroisoquinoline derivatives and their actions at the adrenoreceptors.
    Glinka R; Cieśliński M; Idowski P
    Acta Pol Pharm; 1995; 52(3):241-4. PubMed ID: 8960255
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of some isoindolines and 1,2,3,4-tetrahydroisoquinolines and their evaluation as alpha-adrenergic and adrenergic neuron blocking agents.
    Casagrande C; Galli A; Ferrini R; Miragoli G
    Farmaco Sci; 1972 Jun; 27(6):445-70. PubMed ID: 4402509
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activity.
    Kubota H; Kakefuda A; Watanabe T; Ishii N; Wada K; Masuda N; Sakamoto S; Tsukamoto S
    J Med Chem; 2003 Oct; 46(22):4728-40. PubMed ID: 14561092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,2,3,4-tetrahydroisoquinoline derivatives: a new class of 5-HT1A receptor ligands.
    Mokrosz MJ; Bojarski AJ; Duszyńska B; Tatarczyńska E; Kłodzińska A; Dereń-Wesołek A; Charakchieva-Minol S; Chojnacka-Wójcik E
    Bioorg Med Chem; 1999 Feb; 7(2):287-95. PubMed ID: 10218820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The synthesis and biological activity of substituted tetrahydroisoquinoline compounds].
    Huang WL; Song XQ; Peng SX; Huang ZY
    Yao Xue Xue Bao; 1990; 25(11):815-23. PubMed ID: 1983058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 3-trifluoromethyl-7-substituted-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
    Grunewald GL; Caldwell TM; Li Q; Criscione KR
    J Med Chem; 1999 Aug; 42(17):3315-23. PubMed ID: 10464018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton.
    Gitto R; Caruso R; Pagano B; De Luca L; Citraro R; Russo E; De Sarro G; Chimirri A
    J Med Chem; 2006 Sep; 49(18):5618-22. PubMed ID: 16942035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on angiotensin converting enzyme inhibitors. II. Syntheses and angiotensin converting enzyme inhibitory activities of carboxyethylcarbamoyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives.
    Hayashi K; Nunami K; Sakai K; Ozaki Y; Kato J; Kinashi K; Yoneda N
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3553-61. PubMed ID: 6323041
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis, resolution, and renal vasodilation activity of novel DA1 agonists: 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives.
    Anan H; Tanaka A; Tsuzuki R; Yokota M; Yatsu T; Honda K; Asano M; Fujita S; Furuya T; Fujikura T
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2910-4. PubMed ID: 1839245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.